CDX ASX Chart
Snapshot
Cardiex Limited (CDX) mission is to improve longevity through medical technology focused on vascular health. The company develops products that include medical devices, home health devices, and digital solutions for hypertension, cardiovascular disease, and vascular health disorders, based on its SphygmoCor vascular biomarker technology.
Share Price Activity (ASX)
Last (Price) | |
Change | 0.00 (0.00) |
Bid / Ask | - |
Volume | |
Volume (4w avg) | |
Turnover | |
Open | |
Day Range | - |
VWAP | |
Prev Close | |
Last Trade |
Performance
1 Week | |
1 Month | |
2025 YTD | |
1 Year | |
vs Sector (1yr) | -7.51% |
vs ASX 200 (1yr) | -14.35% |
Announcements
Corporate Overview
Corporate Details
Head Office | Sydney NSW 2000 |
Website | www.CardieX.com |
Registry | Automic Group |
Auditor | BDO Audit Pty Ltd |
Date Listed | 9 Nov 2005 |
Upcoming Calendar (Forecasted)
Date | Event |
---|---|
27/02/2025 | Report (Interim) |
29/08/2025 | Report (Prelim) |
29/09/2025 | Report (Annual) |
Former Company Names
- AtCor Medical Holdings Limited (ACG), 15/06/2018
Sponsored Financial Content
Dividend History
DPS and Yield calculations use the Pay Date.
See Upcoming Dividends for all ASX companies.
Directors & Management
Directors
Management
Director Transactions
CDX directors must report any change in shareholding to the ASX within 5 business days.
See Director Transactions for all ASX companies.
Director Interests
The current holdings of CDX directors.
Shareholder Info
Substantial Shareholders
A substantial shareholder is a person or entity that owns 5% or more of the voting shares in a company. Shares can be held through multiple entities, so the Substantial Shareholders list differs from the Top 20 Shareholders list.
Shareholding changes less than 1% do not require notification to the market. When all “Last Notice” dates are identical, it suggests that no (or minimal) change has occurred since the most recent Annual Report.
Note: If a substantial shareholder's stake drops below 5%, the "Shareholders Selling" field shows full ownership as sold and sets "New %" to zero, even if they continue to hold shares under the limit.
Name | Last Notice | Total Shares | Shares Held (%) |
---|---|---|---|
John Charles Plummer | 27/09/2024 | 17,843,316 | 6.07 |
C2 Ventures Pty Ltd | 30/12/2024 | 145,689,830 | 35.95 |
Regal Funds Management Pty Ltd | 30/12/2024 | 24,132,898 | 5.96 |
Shareholders Buying
12 month transaction history compiled from ASX announcements.
Date | Name | Bought | Previous % | New % |
---|---|---|---|---|
30-12-24 | C2 Ventures Pty Ltd | 77,000,000 | 23.35 | 35.95 |
24-12-24 | Regal Funds Management Pty Ltd | 24,132,898 | -- | 7.31 |
25-03-24 | Bank of America Corporation and its related bodies corporate | 20,847,625 | -- | 7.09 |
Shareholders Selling
12 month transaction history compiled from ASX announcements.
Date | Name | Sold | Previous % | New % |
---|---|---|---|---|
02-12-24 | Regal Funds Management Pty Ltd | 17,766,683 | 6.04 | -- |
04-10-24 | Regal Funds Management Pty Ltd | 3,650,730 | 7.28 | 6.04 |
27-05-24 | Bank of America Corporation and its related bodies corporate | 15,904,246 | 5.41 | -- |
26-04-24 | Bank of America Corporation and its related bodies corporate | 4,943,379 | 7.09 | 5.41 |
18-04-24 | Regal Funds Management Pty Ltd | 3,629,664 | 8.51 | 7.28 |
Historical Data
Share Price History
Date | Close | Change | %Chg | Open | High | Low | Volume | Turnover |
---|---|---|---|---|---|---|---|---|
Historical Data
Year | Closing Price | Last Trade |
---|---|---|
2024 | $0.07 | 28 June |
2023 | $0.155 | 30 June |
2022 | $0.31 | 30 June |
2021 | $0.071 | 30 June |
2020 | $0.021 | 30 June |
2019 | $0.026 | 28 June |
2018 | $0.026 | 29 June |
2017 | $0.035 | 30 June |
2016 | $0.125 | 30 June |
2015 | $0.18 | 30 June |
2014 | $0.094 | 30 June |
Important note:
All year-end and CSV data is "as traded on the day" and ignores corporate actions (e.g. share splits)

All data on this page is supplied by the ASX, Morningstar and Market Index. Read the disclaimer.